Location: Caldwell
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Caldwell
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · Alliance for Clinical Trials in Oncology · NCT07321652 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer NA · Saint Alphonsus Cancer Care Center-Caldwell · Alliance for Clinical Trials in Oncology · NCT07091617 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · Alliance for Clinical Trials in Oncology · NCT06632327 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · Canadian Cancer Trials Group · NCT06592924 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · SWOG Cancer Research Network · NCT05806515 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects Phase N/A · Saint Alphonsus Cancer Care Center-Caldwell · Alliance for Clinical Trials in Oncology · NCT04242095 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT05256225 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT05554393 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · NRG Oncology · NCT05327686 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · NRG Oncology · NCT04852887 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · Alliance for Clinical Trials in Oncology · NCT05677490 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT06058377 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60 Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · SWOG Cancer Research Network · NCT04511013 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps NA · Saint Alphonsus Cancer Care Center-Caldwell · NRG Oncology · NCT05080673 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers Phase N/A · Saint Alphonsus Cancer Care Center-Caldwell · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo Phase 2/Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT05987241 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT05564377 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · SWOG Cancer Research Network · NCT04205968 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT06317649 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · Alliance for Clinical Trials in Oncology · NCT05008848 Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors ( Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT06126276 Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · ECOG-ACRIN Cancer Research Group · NCT04423211 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · ECOG-ACRIN Cancer Research Group · NCT02734537 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Phase 2/Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · SWOG Cancer Research Network · NCT06616584 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Phase 3 · Saint Alphonsus Cancer Care Center-Caldwell · SWOG Cancer Research Network · NCT03418961 Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta Phase 2 · Saint Alphonsus Cancer Care Center-Caldwell · National Cancer Institute (NCI) · NCT06029270
Look up another city
Look up another condition